The extrathyroidal effect of D,L-propranolol on 3,3',5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine kinetics.

作者: I. B. LUMHOLTZ , J. FABER , C. KIRKEGAARD , K. SIERSBÆK-NIELSEN , T. FRIIS

DOI: 10.1210/JCEM-54-6-1097

关键词:

摘要: The effect of D,L-propranolol (80 mg daily) on the peripheral monodeiodination rT3, 3',5'-diiodothyronine (3',5'-T2), 3,3'-diiodothyronine (3,3'-T2), and 3'-monoiodothyronine (3'-T1) was studied in seven out-patients with severe pretreatment hypothyroidism. patients were maintained euthyroid a constant L-T4 replacement therapy. A bolus injection technique used; MCR, production rate (PR), conversion determined using noncompartmental kinetic model. During D,L-propranolol, serum rT3 3',5'-T2 increased (P less than 0.02), 3,3'-T2 seemed to decrease. MCRs 3',5'-T2, 0.02) decreased during drug treatment. MCR PR 3'-T1 reduced, albeit not significantly 0.10). reduced whereas PRs unaltered. No changes seen apparent distribution volumes iodothyronines studied. results are compatible assumption that or metabolite thereof, inhibits 5'-deiodination all iodothyronines.

参考文章(36)
J. SAUNDERS, SUSAN E. H. HALL, A. CROWTHER, P. H. SÖNKSEN, THE EFFECT OF PROPRANOLOL ON THYROID HORMONES AND OXYGEN CONSUMPTION IN THYROTOXICOSIS Clinical Endocrinology. ,vol. 9, pp. 67- 72 ,(1978) , 10.1111/J.1365-2265.1978.TB03573.X
R.P. Verhoeven, T.J. Visser, R. Docter, G. Hennemann, M.A.D.H. Schalekamp, PLASMA THYROXINE, 3,3′,5-TRIIODOTHYRONINE AND 3,3′,5′-TRIIODOTHYRONINE DURING 3-ADRENERGIC BLOCKADE IN. HYPERTHYROIDISM The Journal of Clinical Endocrinology and Metabolism. ,vol. 44, pp. 1002- 1005 ,(1977) , 10.1210/JCEM-44-5-1002
W. M. WIERSINGA, J. L. TOUBER, The Influence of β-Adrenoceptor Blocking Agents on Plasma Thyroxine and Triiodothyronine The Journal of Clinical Endocrinology and Metabolism. ,vol. 45, pp. 293- 298 ,(1977) , 10.1210/JCEM-45-2-293
P. Theilade, J.M. Hansen, L. Skovsted, J. Faber, C. Kirkegård, T. Friis, K. Siersbaek-Nielsen, PROPRANOLOL INFLUENCES SERUM T3 AND REVERSE T3 IN HYPERTHYROIDISM The Lancet. ,vol. 310, pp. 363- ,(1977) , 10.1016/S0140-6736(77)91532-X
Ove R. Nilsson, Bengt E. Karlberg, Bertil Kågedal, Lennart Tegler, Sven Almqvist, Non-Selective and Selective β-1-Adrenoceptor Blocking Agents in the Treatment of Hyperthyroidism Acta Medica Scandinavica. ,vol. 206, pp. 21- 25 ,(2009) , 10.1111/J.0954-6820.1979.TB13463.X
O. R. Nilsson, A. Melander, L. Tegler, Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients. European Journal of Clinical Pharmacology. ,vol. 18, pp. 315- 320 ,(1980) , 10.1007/BF00561388
P Heyma, R G Larkins, L Higginbotham, K W Ng, D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine. BMJ. ,vol. 281, pp. 24- 25 ,(1980) , 10.1136/BMJ.281.6232.24
L. Wong, RL Nation, WL Chiou, PK Mehta, Plasma concentrations of propranolol and 4‐hydroxypropranolol during chronic oral propranolol therapy. British Journal of Clinical Pharmacology. ,vol. 8, pp. 163- 167 ,(1979) , 10.1111/J.1365-2125.1979.TB05815.X
KENNETH D. BURMAN, FRANCES D. WRIGHT, ROBERT C. SMALLRIDGE, BILL J. GREEN, LEON P. GEORGES, LEONARD WARTOFSKY, A radioimmunoassay for 3',5'-diiodothyronine. The Journal of Clinical Endocrinology and Metabolism. ,vol. 47, pp. 1059- 1064 ,(1978) , 10.1210/JCEM-47-5-1059